✦ LIBER ✦

A Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT-EXT Study)

✍ Scribed by A. Durrbach; J. M. Pestana; T. Pearson; F. Vincenti; V. D. Garcia; J. Campistol; M. Del Carmen Rial; S. Florman; A. Block; G. Di Russo; J. Xing; P. Garg; J. Grinyó

Book ID: 114805495
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 119 KB
Volume: 10
Category: Article
ISSN: 1600-6135
DOI: 10.1111/j.1600-6143.2010.03016.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Three-Year Outcomes From BENEFIT-EXT: A

Three-Year Outcomes From BENEFIT-EXT: A Phase III Study of Belatacept Versus Cyclosporine in Recipients of Extended Criteria Donor Kidneys

✍ J. O. Medina Pestana; J. M. Grinyo; Y. Vanrenterghem; T. Becker; J. M. Campistol 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 619 KB

A Phase III Study of Belatacept-based Im

A Phase III Study of Belatacept-based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)

✍ F. Vincenti; B. Charpentier; Y. Vanrenterghem; L. Rostaing; B. Bresnahan; P. Dar 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

Improvement in renal function in kidney

Improvement in renal function in kidney transplant recipients switched from cyclosporine or tacrolimus to belatacept: 2-year results from the long-term extension of a phase II study

✍ Josep Grinyo; Josefina Alberu; Fabiana L. C. Contieri; Roberto C. Manfro; Guille 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 196 KB

Pharmacokinetics of Once- Versus Twice-D

Pharmacokinetics of Once- Versus Twice-Daily Tacrolimus Formulations in Kidney Transplant Patients Receiving Expanded Criteria Deceased Donor Organs: A Single-Center, Randomized Study

✍ M. Cabello; P. García; M. González-Molina; M.J. Díez de los Rios; M. García-Sáiz 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 106 KB

The efficacy and safety of mizoribine in

The efficacy and safety of mizoribine in living donor kidney transplantation: a 24-week, open-label, prospective study (phase III clinical trial)

✍ D.K. Cho; J.H. Kim; S.H. Park; J.C. Kim; C.D. Kim; M.Y. Baek; S.J. Kim; S.H. Kim 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 53 KB